Skip to content

BIOZOOM, INC.: 10-Q filed 2012-02-21

What BIOZOOM, INC. reported in its quarterly report filed 2012-02-21 (fiscal Q3 2011): 18 published measures, 57 facts as tagged in accession 0001477932-12-000486.

This filing

Form
10-Q (quarterly report)
Filed
2012-02-21
Fiscal period
fiscal Q3 2011
Accession
0001477932-12-000486 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All BIOZOOM, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-12-31772USD
At 2011-03-3113USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-12-3177,079USD
At 2011-03-3186,337USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-12-31-76,307USD
At 2011-03-31-86,324USD
At 2010-03-31-56,476USD
At 2009-03-31-26,677USD
At 2008-03-3126,725USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-03-3113USD
At 2010-03-313,792USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-10-01 to 2011-12-3127,685USD92
2011-04-01 to 2011-12-3110,017USD275
2007-06-15 to 2011-12-31-142,407USD1661
2010-04-01 to 2011-03-31-29,848USD365
2010-10-01 to 2010-12-31-4,907USD92
2010-04-01 to 2010-12-31-22,229USD275
2009-04-01 to 2010-03-31-29,799USD365
2008-04-01 to 2009-03-31-53,402USD365
2007-06-15 to 2008-03-31-39,375USD291

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-04-01 to 2011-12-31-27,241USD275
2007-06-15 to 2011-12-31-161,328USD1661
2010-04-01 to 2010-12-31-14,615USD275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2007-06-15 to 2011-12-311,500USD1661

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-04-01 to 2011-12-3128,000USD275
2007-06-15 to 2011-12-31162,100USD1661
2010-04-01 to 2010-12-3113,000USD275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2011-10-01 to 2011-12-3159,730,000shares92
2011-04-01 to 2011-12-3159,730,000shares275
2010-10-01 to 2010-12-3159,730,000shares92
2010-04-01 to 2010-12-3159,730,000shares275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-10-01 to 2011-12-31-3,429USD92
2011-04-01 to 2011-12-31-18,349USD275
2007-06-15 to 2011-12-31-169,422USD1661
2010-10-01 to 2010-12-31-3,876USD92
2010-04-01 to 2010-12-31-19,139USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-12-31772USD
At 2011-03-3113USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-10-01 to 2011-12-311,135USD92
2011-04-01 to 2011-12-313,883USD275
2007-06-15 to 2011-12-3111,327USD1661
2010-10-01 to 2010-12-311,031USD92
2010-04-01 to 2010-12-313,090USD275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-12-3161,679USD
At 2011-03-3186,337USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-12-3159,730,000shares
At 2011-03-3159,730,000shares

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2011-12-3115,400USD
At 2011-03-310USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-12-319,679USD
At 2011-03-3118,337USD

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-10-01 to 2011-12-3131,114USD92
2011-04-01 to 2011-12-3128,366USD275
2007-06-15 to 2011-12-3127,015USD1661
2010-10-01 to 2010-12-31-1,031USD92
2010-04-01 to 2010-12-31-3,090USD275

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2007-06-15 to 2011-12-3166,100USD1661

Inspect the source

Entity
BIOZOOM, INC. / CIK 0001438576
Captured
SEC response SHA-256
10fceb63ca08d6e2bef1dec96ccb8beef396faa297dc882139e68e2d4e0f8bf2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001438576.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))